Once weekly semaglutide and cardiovascular outcomes in patients with type 2 diabetes and heart failure with reduced left ventricular ejection fraction.

Rev Esp Cardiol (Engl Ed)

Servicio de Medicina Interna, Hospital Regional Universitario de Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Departamento de Medicina y Dermatología, Facultad de Medicina, Universidad de Málaga (UMA), Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain; Servicio de Medicina Interna, Hospital Helicópteros Sanitarios, Marbella, Spain; Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares (CIBERCV), Instituto de Salud Carlos III, Madrid, Spain. Electronic address:

Published: July 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.rec.2023.12.008DOI Listing

Publication Analysis

Top Keywords

weekly semaglutide
4
semaglutide cardiovascular
4
cardiovascular outcomes
4
outcomes patients
4
patients type
4
type diabetes
4
diabetes heart
4
heart failure
4
failure reduced
4
reduced left
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!